Study Stopped
Suspended due to COVID-19
tDCS to Treat Subacute Aphasia
Transcranial Direct Current Stimulation to Enhance Language Recovery in Patients With Aphasia After Subacute Stroke
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study proposes to use transcranial direct current stimulation (tDCS), a technique by which a very small electrical current (2 mA) is applied to the scalp, along side speech therapy in patients with subacute stroke and aphasia in order to enhance language recovery. Aphasic patients in an inpatient neurorehabilitation facility who have experienced a stroke between one week and three months prior to enrollment will be invited to participate. Participants will receive either real or sham tDCS to the left hemisphere of the brain for a minimum of 5 consecutive sessions to up-to a max of 10 sessions depending on the length of their rehab stay . Stimulation will be paired with with the patient's normal speech therapy schedule. Participant's language skills will be assessed at baseline and immediately after the last session of therapy in order to determine whether tDCS is associated with either transient or persistent improvement in language.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2019
CompletedFirst Posted
Study publicly available on registry
August 7, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedAugust 7, 2024
August 1, 2024
2.9 years
August 5, 2019
August 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Aphasia Severity
Measured by WAB AQ score. A higher score indicated better language function. Scores can range from 0-100 with any score over 93 considered "recovered".
Baseline, Immediate Follow-up
Study Arms (2)
Anodal tDCS
ACTIVE COMPARATOR2mA for 20 minutes
Sham tDCS
SHAM COMPARATOR30 second ramp-up / ramp-down for 20 minutes
Interventions
tDCS is a non-invasive brain stimulation technique by which very small electrical currents (2 mA) are applied to the scalp.
Eligibility Criteria
You may qualify if:
- \. Must be able to understand the nature of the study, and give informed consent.
- \. English must be their native language where "native" is defined as learning English before the age of 6
You may not qualify if:
- \. History of chronic, serious, or unstable neurologic illness(es) other than stroke
- \. Current unstable medical illness(es)
- \. History of reoccurring seizures or epilepsy
- \. Current abuse of alcohol or drugs
- \. Active or History of major psychiatric disorder
- \. Pregnancy
- \. Subjects with metallic objects in the face or head other than dental apparatus such as braces, fillings, and implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn Institute for Rehabilitation Medicine
Philadelphia, Pennsylvania, 19146, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2019
First Posted
August 7, 2019
Study Start
September 1, 2019
Primary Completion
July 15, 2022
Study Completion
July 1, 2024
Last Updated
August 7, 2024
Record last verified: 2024-08